Boviseal produces a seal which provides a physical barrier and prevents new intramammary infections in the udder during the dry period.
Boviseal is licensed for the prevention of new intramammary infections throughout the dry period. This results in a reduction in the incidence of subclinical mastitis in the dry period and the subsequent lactation (for at least 60 days after calving).
Infusion of Boviseal into each udder quarter produces a seal in the teat that provides an immediate and long lasting physical barrier to entry of bacteria and other mastitis causing organisms.
Click here to find out more about #SealingTheFuture
Package Quantities: Buckets of 120 or 200 single dose intramammary syringes
Presentation: Grey to white coloured cream containing Bismuth subnitrate 2.6 g per syringe.Also contains liquid paraffin, alumium di tri-stearate and colloidal anydrous silica.
You are now leaving the regional website to access another site in the group.
Regulatory constraints and medical practices vary across regions from market to market. Consequently, the information provided on the site in which you enter may not be suitable for use in your region.